Abstract
This multicenter, double-masked, randomized, parallel-group study compared the efficacy and safety of ketorolac tromethamine 0.5% ophthalmic solution with levocabastine 0.05% and ketorolac tromethamine vehicle in patients with seasonal allergic conjunctivitis. One drop of ketorolac, levocabastine, or vehicle was instilled in each eye four times daily for 6 weeks. In the majority of efficacy variables, ketorolac produced the greatest improvements, followed by levocabastine and vehicle. Ketorolac was significantly more effective (P<.05) than vehicle in reducing mean itching scores, palpebral hyperemia, bulbar hyperemia, and edema. Patients treated with ketorolac reported significant improvements (P<.05) in their ability to sleep and to concentrate on work, compared with those who received vehicle. No significant differences were noted among the treatment groups in safety or tolerability. Ketorolac tromethamine 0.5% ophthalmic solution instilled four times daily is effective and safe in reducing the signs and symptoms of seasonal allergic conjunctivitis.
Similar content being viewed by others
References
Allansmith MR, Greiner JV, Baird RS. Number of inflammatory cells in the normal conjunctiva.Am J Ophthalmol. 1978;86:250–259.
Capetola RJ, Rosenthale ME, Dubinsky B, McGuire JL. Peripheral analgesics.Clin Pharmacol. 1983;23:545–556.
Abelson MB, Butrus SI, Kliman GH, et al. Topical arachidonic acid: a model for screening anti-inflammatory agents.J Ocul Pharmacol. 1987;3:63–75.
Tinkelman DG, Rupp G, Kaufman H, Pugely J, Schultz N. Double-masked, paired-comparison clinical study of ketorolac tromethamine 0.5% ophthalmic solution compared with placebo eyedrops in the treatment of seasonal allergic conjunctivitis.Surv Ophthalmol. 1993;38:133–140.
Ballas Z, Blumenthal M, Tinkelman DG, Kriz R, Ruff G. Clinical evaluation of ketorolac tromethamine 0.5% ophthalmic solution for the treatment of seasonal allergic conjunctivitis.Surv Ophthalmol. 1993;38:141–148.
Bahmer FA, Ruprecht KW. Safety and efficacy of topical levocabastine compared with oral terfenadine.Ann Allergy. 1994;72:429–434.
Dawson JP. Comparative trial of 2% sodium cromoglycate unit-dose eye drops in seasonal allergic conjunctivitis. In: Pepys J, Edwards EM, eds.The Mast Cell. Its Role in Health and Disease. London: Pitman Medical; 1979:506–511.
Abelson MB, Chambers WA, Smith LM. Conjunctival allergen challenge—A clinical approach to studying allergic conjunctivitis.Arch Ophthalmol. 1990;108:84–88.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Donshik, P.C., Pearlman, D., Pinnas, J. et al. Efficacy and safety of ketorolac tromethamine 0.5% and levocabastine 0.05%: a multicenter comparison in patients with seasonal allergic conjunctivitis. Adv Therapy 17, 94–102 (2000). https://doi.org/10.1007/BF02854842
Issue Date:
DOI: https://doi.org/10.1007/BF02854842